These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 579515

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Anti-thormbin III and heparin clotting times in thrombosis and atherosclerosis.
    O'Brien JR.
    Thromb Diath Haemorrh; 1974 Sep 30; 32(1):116-23. PubMed ID: 4454034
    [Abstract] [Full Text] [Related]

  • 3. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T, von Lessen A, Welters I, Wagner RM, Ruwoldt R, Boldt J, Hempelmann G.
    Infusionsther Transfusionsmed; 1994 Aug 30; 21(4):244-50. PubMed ID: 7950289
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Short heparin thrombin clotting time, increased fibrinogen and platelet aggregates count in coronary disease: a probable hypercoagulable state.
    Patrassi GM, Toffanin F, Massa G, Schivazappa L, Girolami A.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979 Aug 30; 106(3):414-25. PubMed ID: 89993
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Coagulation factors influencing thrombosis of aorta-coronary bypass grafts.
    Zajtchuk R, Collins GJ, Holley PW, Heydron WH, Schuchmann GF, Hamaker WR.
    J Thorac Cardiovasc Surg; 1977 Feb 30; 73(2):309-11. PubMed ID: 299908
    [Abstract] [Full Text] [Related]

  • 8. Clinical study of platelet function and coagulation/fibrinolysis with Duraflo II heparin coated cardiopulmonary bypass equipment.
    Nakajima T, Osawa S, Ogawa M, Sasaki T, Izumoto H, Yagi Y, Kawazoe K.
    ASAIO J; 1996 Feb 30; 42(4):301-5. PubMed ID: 8828788
    [Abstract] [Full Text] [Related]

  • 9. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
    Bohner J, von Pape KW, Blaurock M.
    Thromb Haemost; 1994 Mar 30; 71(3):280-3. PubMed ID: 8029789
    [Abstract] [Full Text] [Related]

  • 10. Alteration of plasma antithrombin III levels in ischemic heart disease.
    Yue RH, Gertler MM, Starr T, Koutrouby R.
    Thromb Haemost; 1976 Jun 30; 35(3):598-606. PubMed ID: 989967
    [Abstract] [Full Text] [Related]

  • 11. [Significance of the inhibitors in disseminated intravascular coagulation syndrome and relationship among antithrombin III, platelet factor 4 and heparin (author's transl)].
    Sakuragawa N, Takahashi K, Hoshiyama M, Matsuoka M.
    Nihon Ketsueki Gakkai Zasshi; 1977 Apr 30; 40(2):218-26. PubMed ID: 578067
    [No Abstract] [Full Text] [Related]

  • 12. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
    Rezaie AR.
    Thromb Res; 2007 Apr 30; 119(4):481-8. PubMed ID: 16515805
    [Abstract] [Full Text] [Related]

  • 13. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.
    Sas G, Blaskó G, Bánhegyi D, Jákó J, Pálos LA.
    Thromb Diath Haemorrh; 1974 Sep 30; 32(1):105-15. PubMed ID: 4454033
    [Abstract] [Full Text] [Related]

  • 14. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
    Tran TH, Duckert F.
    Thromb Haemost; 1984 Oct 31; 52(2):112-6. PubMed ID: 6395434
    [Abstract] [Full Text] [Related]

  • 15. Antiplatelet and antithrombin therapies in the acute coronary syndromes.
    Alexander JH, Harrington RA.
    Curr Opin Cardiol; 1997 Jul 31; 12(4):427-37. PubMed ID: 9263656
    [Abstract] [Full Text] [Related]

  • 16. [Hypercoagulability in atrial fibrillation and its relationship with risk factors for systemic embolism].
    Pérez LA, Corbalán R, Acevedo M, Pereira J, Braun S, Tapia J, Kramer A, Lira MT, Huete I, Sepúlveda G, Springmüller D.
    Rev Med Chil; 2002 Oct 31; 130(10):1087-94. PubMed ID: 12491825
    [Abstract] [Full Text] [Related]

  • 17. The measurement of thrombin in clotting blood by radioimmunoassay.
    Shuman MA, Majerus PW.
    J Clin Invest; 1976 Nov 31; 58(5):1249-58. PubMed ID: 993343
    [Abstract] [Full Text] [Related]

  • 18. Platelet function in acute myocardial infarction patients compared with controls.
    O'Brien JR, Etherington MD, Shuttleworth RD, Calwell WH.
    Thromb Haemost; 1980 Oct 31; 44(2):96-9. PubMed ID: 7455998
    [Abstract] [Full Text] [Related]

  • 19. A rational approach to heparins.
    Hemker HC, Béguin S.
    Nouv Rev Fr Hematol (1978); 1992 Oct 31; 34(1):5-9. PubMed ID: 1326098
    [Abstract] [Full Text] [Related]

  • 20. Release of platelet factor 4 in vivo during intravascular coagulation and in thrombotic states.
    Farbiszewski R, Niewiarowski S, Worowski K, Lipiński B.
    Thromb Diath Haemorrh; 1968 Jul 31; 19(3):578-83. PubMed ID: 4236824
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.